Dana Investment Advisors’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Buy
15,761
+385
+3% +$24.5K 0.03% 400
2025
Q4
$977K Sell
15,376
-2,037
-12% -$127K 0.03% 393
2025
Q3
$957K Buy
17,413
+811
+5% +$33.4K 0.03% 397
2025
Q2
$549K Sell
16,602
-401
-2% -$13.9K 0.02% 444
2025
Q1
$683K Buy
17,003
+140
+0.8% +$6.43K 0.02% 415
2024
Q4
$793K Sell
16,863
-169
-1% -$8.78K 0.03% 415
2024
Q3
$899K Buy
17,032
+1,082
+7% +$60.3K 0.03% 393
2024
Q2
$864K Sell
15,950
-35
-0.2% -$2.11K 0.03% 390
2024
Q1
$1.12M Sell
15,985
-1,136
-7% -$87.9K 0.04% 361
2023
Q4
$1.43M Sell
17,121
-1,295
-7% -$46.9K 0.07% 208
2023
Q3
$543K Sell
18,416
-1,829
-9% -$60.9K 0.03% 298
2023
Q2
$660K Buy
20,245
+295
+1% +$10.9K 0.03% 286
2023
Q1
$702K Buy
19,950
+1,349
+7% +$55K 0.04% 278
2022
Q4
$852K Buy
18,601
+2,994
+19% +$129K 0.04% 250
2022
Q3
$756K Sell
15,607
-211
-1% -$10.2K 0.04% 252
2022
Q2
$621K Sell
15,818
-1,533
-9% -$61.7K 0.03% 287
2022
Q1
$639K Buy
17,351
+489
+3% +$17.4K 0.03% 251
2021
Q4
$769K Sell
16,862
-2,483
-13% -$95.8K 0.03% 232
2021
Q3
$691K Sell
19,345
-5,866
-23% -$173K 0.03% 228
2021
Q2
$499K Sell
25,211
-111
-0.4% -$2.61K 0.02% 250
2021
Q1
$589K Buy
+25,322
New +$541K 0.03% 242

Other funds holding CYTK